Marijuana & Legalization
China says marijuana legalization to blame for US opioid crisis
Several states likely to legalize marijuana in 2018
Helping settle the marijuana and alcohol debate
Could Ohio, other states lose exemption from marijuana prosecution?
Does medical marijuana really work? The truth behind the buzz.
Marijuana & Health
A doctor reveals exactly how to use cannabis for anxiety
FDA accepts GW Pharma’s NDA filing for Epidiolex in the treatment of LGS and Dravet syndrome
12/28/17--GW Pharmaceuticals (NASDAQ:GWPH) announces that the FDA has accepted for filing with Priority Review its recently submitted New Drug Application (NDA) for Epidiolex (cannabidiol or CBD), an investigational treatment for seizures associated with Lennox-Gastaut syndrome (LGS) and Dravet syndrome, two rare and difficult to treat conditions of childhood-onset epilepsy. The Prescription Drug User Fee Act goal date for completion of the FDA review of the Epidiolex NDA is June 27, 2018. Read